Table 3. Analysis of the relationship between tumor mutation data and immune typing.

Number of somatic mutations	FUT4/ELANE groups			FUT4/MPO groups
	r	P		r	P
ACC	−0.194	0.088		−0.328	0.003
HNSC	0.097	0.106		0.072	0.228
COADREAD	−0.092	0.118		−0.063	0.363
LGG	−0.104	0.080		−0.071	0.229
PRAD	−0.082	0.186		−0.178	0.004
KIRP	0.089	0.251		0.090	0.245
SKCM	−0.063	0.232		−0.123	0.020
ESCA	−0.255	0.001		−0.243	0.002
LUAD	−0.051	0.455		0.104	0.122
GBM	0.046	0.593		−0.129	0.133
CESC	0.043	0.555		0.129	0.075
UCEC	−0.632	0.252		0.105	0.866
BRCA	−0.186	<0.001		−0.095	0.003
PAAD	−0.243	0.003		−0.135	0.105
BLCA	−0.039	0.664		0.078	0.379

FUT4, fucosyltransferase 4; ELANE, elastase, neutrophil expressed; MPO, myeloperoxidase; BLCA, bladder urothelial carcinoma; BRCA, breast cancer; CESC, cervical cancer; GBM, glioblastoma multiforme; KIRP, kidney renal papillary cell carcinoma; LUAD, lung adenocarcinoma; ESCA, esophageal carcinoma; HNSC, head and neck squamous cell carcinoma; LGG, brain lower grade glioma; COADREAD, colorectal and rectal cancer; SKCM, skin cutaneous melanoma; ACC, adrenocortical carcinoma; UCEC, uterine corpus endometrial carcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma.